The TIME CRC program allows Tempus to place an employee at a TIME site with a protected bandwidth to carry out all TIME related operations. This program aims to overcome the resource constraints known to affect research teams, and support TIME sites in utilization of the TIME portfolio to ultimately boost enrollment in clinical trials.

The first TIME CRC hired was Rachel Harmon, at the Center for Cancer and Blood Disorders (CCBD) in Bethesda, MD. CCBD is a small community oncology practice that has been a TIME site since August 2020. The CCBD Research Director, Natalie Bongiorno, recognizes the burden of allocating resources between their current clinical trial portfolio and rapid activations, as clinical trials have become more laborious, mutation specific, and resource heavy. Bongiorno describes her site’s TIME CRC as the “extra set of hands that every research department needs.” With Rachel as a dedicated resource, in the first 10 months the site was able to grow their TIME clinical trial program through:

• 6 additional trials opened within 6 months
• 4.2x expansion in trial activations
• 7.7x growth in trial consents
• 6.3x increase in subject enrollment

The physicians at CCBD have seen the merit in this program, with Dr. Mark Goldstein saying Rachel “has taken the burden off of our employed trials staff, and allows for an efficient process to identify appropriate trials for patients.”

Tempus is expanding this program and extending CRC resources health system collaborators with strong activity in TIME that we can turbocharge further. By providing research teams with this dedicated asset, we continue to advance the TIME Program’s mission of bringing relevant, cutting edge therapies to a patient’s local oncologist, increasing enrollment rates across clinical trials, and improving the rate of clinical trial completion and therapy approval, to make life saving medications available on a larger scale.

If you and your team are interested in learning more about the TIME CRC Program, please contact your Site Account Manager.

Natalie’s quote: “As cancer development continues to get more laborious, mutation specific, and resource heavy, the TIME program allows sites to elevate their research program. TIME helps create a cutting edge trial menu that sets their clinic apart from other facilities and offers state of the art care for community oncology patients. TIME is that extra set of hands that every research department needs!”

Dr. Goldstein’s quote: “Having a TIME CRC in house has taken the burden off of our employed trials staff, and allows for an efficient process to identify appropriate trials for patients who may match based on both Tempus and non-Tempus NGS tests.”